ari scientists
Diane V. Havlir, MD
Diane V. Havlir, MD, is chief of the HIV/AIDS division and Positive Health Program at San Francisco General Hospital, professor of medicine at UCSF, and principal investigator for the Adult AIDS Clinical Trials Group (AACTG) at UCSF. She has worked as a researcher and clinician in the HIV epidemic for over twenty years. Dr. Havlir began her medical career as an intern and resident in internal medicine at UCSF after earning her MD degree at Duke University Medical School in 1984.
Dr. Havlir spearheaded early studies of opportunistic infection treatment and prophylaxis, and conducted pivotal studies on nevirapine viral dynamics, antiretroviral therapeutic strategies, and HIV drug resistance. She is currently directing several antiretroviral treatment trials and is the principal investigator on two international trials of HIV and co-infections (tuberculosis and malaria). She was elected to the American Society for Clinical Investigation and is a member of the World Health Organization HIV treatment guidelines committee, a founding member of the WHO International HIV Drug Surveillance Program, and the North American representative to the International AIDS Society. In 2006, she was elected to chair the TB/HIV Working Group of the WHO Stop TB Partnership. Dr. Havlir’s research accomplishments were recognized recently when she received the HIV Research Achievement Award of the Infectious Diseases Society of America and HIV Medicine Association.
